首页 > 市场调查报告书 > 医疗设备

医学影像诊断核子医学

市场调查报告书

商品编码

1729417

日本放射性药物市场报告（按产品类型、应用、最终用途和地区）2025-2033

Japan Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024 年，日本放射性药物市场规模达 2.558 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 6.292 亿美元，2025-2033 年期间的成长率 (CAGR) 为 9.73%。癌症、心血管疾病和神经系统疾病等慢性疾病的发生率不断上升，导致对诊断和治疗放射性药物的需求增加，从而推动了市场的发展。

放射性药物是含有放射性成分（通常是少量放射性同位素）与生物活性分子结合的专用药物。它们在核子医学中用于诊断和治疗目的。在诊断应用中，将放射性药物施用于患者，并使用伽马相机或 PET 扫描仪等影像设备检测其放射性辐射。这使得医疗保健专业人员能够观察和评估体内的各种生理过程，例如血流、器官功能或癌症等特定疾病的存在。放射性药物也可用于治疗某些疾病，如甲状腺疾病和某些类型的癌症。在这些情况下，放射性成分针对特定细胞或组织，提供局部剂量的辐射，从而破坏或控制异常细胞的生长。总体而言，放射性药物在现代医学中发挥着至关重要的作用，它为诊断提供有价值的信息，为特定疾病提供有效的治疗方案，同时最大限度地减少对周围健康组织的辐射暴露。

日本放射性药物市场趋势：

由于几个关键驱动因素，日本放射性药物市场正在经历强劲成长。首先，癌症和心血管疾病等慢性疾病的发生率不断上升，推动了对诊断和治疗放射性药物的需求。此外，日本老龄化人口的不断增长也增加了对先进诊断工具的需求，进一步推动了市场扩张。此外，放射性药物生产和成像技术的进步使得这些药物更加安全、有效，并提高了医疗保健提供者对其的采用率。此外，医疗保健专业人员和患者对早期疾病检测和标靶治疗益处的认识不断提高，这也促进了市场的成长。製药公司和研究机构合作推出新型放射性药物也推动了市场扩张。此外，放射性药物在个人化医疗中的应用不断扩大，以及其在精准治疗策略中的潜力，为市场发展开闢了新的途径，预计将在未来几年推动日本市场的发展。

日本放射性药物市场细分：

产品类型洞察：

诊断核子医学
治疗核子医学

应用程式洞察：

肿瘤学
心臟病学
神经病学
内分泌学
其他的

最终用途洞察：

医院和诊所
研究机构
诊断中心

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本放射性药物市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本放射性药物市场有何影响？
根据产品类型，日本放射性药物市场是如何分類的？
日本放射性药物市场根据应用如何划分？
根据最终用途，日本放射性药物市场是如何分類的？
日本放射性药物市场的价值链分为哪些阶段？
日本放射性药物的主要驱动因素和挑战是什么？
日本放射性药物市场的结构是怎么样的？主要参与者是谁？
日本放射性药物市场的竞争程度如何？

本报告回答的关键问题：

日本放射性药物市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本放射性药物市场有何影响？
根据产品类型，日本放射性药物市场是如何分類的？
日本放射性药物市场根据应用如何划分？
根据最终用途，日本放射性药物市场是如何分類的？
日本放射性药物市场的价值链分为哪些阶段？
日本放射性药物的主要驱动因素和挑战是什么？
日本放射性药物市场的结构是怎么样的？主要参与者是谁？
日本放射性药物市场的竞争程度如何？

Japan radiopharmaceuticals market size reached USD 255.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 629.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.73% during 2025-2033. The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions that has led to an increased demand for diagnostic and therapeutic radiopharmaceuticals, is driving the market.

Radiopharmaceuticals are specialized drugs that contain a radioactive component, typically a small amount of a radioactive isotope, combined with a biologically active molecule. They are used in nuclear medicine for diagnostic and therapeutic purposes. In diagnostic applications, radiopharmaceuticals are administered to patients, and their radioactive emissions are detected using imaging equipment like gamma cameras or PET scanners. This allows healthcare professionals to visualize and assess various physiological processes within the body, such as blood flow, organ function, or the presence of specific diseases like cancer. Radiopharmaceuticals can also be used in therapeutic applications to treat certain medical conditions, such as thyroid disorders and some types of cancer. In these cases, the radioactive component is targeted to specific cells or tissues to deliver a localized dose of radiation, which can destroy or control the growth of abnormal cells. Overall, radiopharmaceuticals play a crucial role in modern medicine by providing valuable information for diagnosis and offering effective treatment options for specific diseases, all while minimizing radiation exposure to surrounding healthy tissues.

Japan Radiopharmaceuticals Market Trends:

The radiopharmaceuticals market in Japan is experiencing robust growth due to several key drivers. Firstly, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has propelled the demand for diagnostic and therapeutic radiopharmaceuticals. Additionally, the growing aging population in Japan has augmented the need for advanced diagnostic tools, further fueling market expansion. Moreover, technological advancements in radiopharmaceutical production and imaging techniques have made these agents safer and more effective, boosting their adoption rates among healthcare providers. Furthermore, a rising awareness among both healthcare professionals and patients about the benefits of early disease detection and targeted therapy has contributed to the market's growth. Collaborative efforts between pharmaceutical companies and research institutions to launch novel radiopharmaceuticals have also propelled market expansion. Furthermore, the expanding application of radiopharmaceuticals in personalized medicine and their potential for precision treatment strategies, which have opened up new avenues for market development, is expected to drive the market in Japan in the coming years.

Japan Radiopharmaceuticals Market Segmentation:

Product Type Insights:

Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine

Application Insights:

Oncology
Cardiology
Neurology
Endocrinology
Others

End Use Insights:

Hospitals and Clinics
Research Institutes
Diagnostic Centers

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan radiopharmaceuticals market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan radiopharmaceuticals market?
What is the breakup of the Japan radiopharmaceuticals market on the basis of product type?
What is the breakup of the Japan radiopharmaceuticals market on the basis of application?
What is the breakup of the Japan radiopharmaceuticals market on the basis of end use?
What are the various stages in the value chain of the Japan radiopharmaceuticals market?
What are the key driving factors and challenges in the Japan radiopharmaceuticals?
What is the structure of the Japan radiopharmaceuticals market and who are the key players?
What is the degree of competition in the Japan radiopharmaceuticals market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Radiopharmaceuticals Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Radiopharmaceuticals Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Radiopharmaceuticals Market - Breakup by Product Type

6.1 Diagnostic Nuclear Medicine
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Therapeutic Nuclear Medicine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Radiopharmaceuticals Market - Breakup by Application

7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Cardiology
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Neurology
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Endocrinology
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Radiopharmaceuticals Market - Breakup by End Use

8.1 Hospitals and Clinics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Diagnostic Centers
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Radiopharmaceuticals Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Radiopharmaceuticals Market - Industry Analysis

11.1 Drivers, Restraints and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis